title: Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab.
authors.forename: M
authors.initials: M
authors.lastname: Bassetti
authors.forename: C
authors.initials: C
authors.lastname: Pizzorni
authors.forename: L
authors.initials: L
authors.lastname: Gradoni
authors.forename: V
authors.initials: V
authors.lastname: Del Bono
authors.forename: M
authors.initials: M
authors.lastname: Cutolo
authors.forename: C
authors.initials: C
authors.lastname: Viscoli
mesh_terms: D000068879:Adalimumab; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000150:complications*; D005260:Female; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000150:complications*; D009894:Opportunistic Infections / Q000150:complications*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000068879:Adalimumab